Congress mandates hearing implant coverage in private insurance plans

What it does

This bill requires private health insurance plans (group and individual) to cover auditory implant devices, cochlear implants, bone-conduction implants, and related services—including surgery, maintenance, upgrades every 5 years, hearing assessments, and rehabilitation—for individuals with hearing loss. Insurance plans cannot impose higher cost-sharing or stricter limits on hearing coverage than they do on other medical benefits, and cannot deny coverage based on medical-necessity reviews if a physician or audiologist determines the device is medically necessary.

Why we flagged it

The bill's core function is a regulatory mandate requiring insurers to cover auditory implants and related services without discriminatory cost-sharing. It is a consumer-protection / health-equity measure, not a tax provision, subsidy, or deregulation.

What the text implies

• Upgrade/replacement every 5 years creates recurring revenue stream for hearing device manufacturers; cost trajectory for insurers is front-loaded but perpetual.
• Prohibition on medical-necessity review limits insurer discretion to challenge coverage determinations; shifts gatekeeping authority to treating physicians/audiologists.
• Applies to grandfathered health plans (those exempt from many ACA requirements), extending mandate reach beyond typical ACA-covered population.
• No explicit cost-containment mechanism (e.g., reference pricing, prior authorization for upgrades); potential for uncapped spending on high-end devices.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Individuals with hearing loss gain access to expensive auditory devices and related medical services that were previously often excluded or subject to restrictive coverage limits. The mandate eliminates discriminatory cost-sharing and treatment limitations, ensuring hearing care is treated as equivalent to other medical benefits. The primary cost falls on insurers and employers, not individual citizens.

Who stands to gain

• hearing device manufacturers (cochlear implant, bone-conduction implant producers)
• audiology practices and hearing centers
• surgical centers performing implant procedures

Named in the bill

Public Health Service Act (PHSA), Employee Retirement Income Security Act (ERISA), Internal Revenue Code (IRC), Patient Protection and Affordable Care Act (ACA), Centers for Medicare & Medicaid Services (CMS), Cochlear Limited, MED-EL, Advanced Bionics, Sonova, GN Store Nord

Where it stands

18 cosponsors: 15 Democrats, 3 Republicans.

• Dec 9, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Dec 9, 2025 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 3 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $966,331 in lobbying spend. A filing names 44 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

John Curtis, the sponsor, reported $431,000 in PAC receipts in the 2026 cycle.

• American Speech-language-hearing Association — $680,000 on 2 filings
• American Academy of Otolaryngology-head and Neck Surgery — $286,331 on 1 filing

Lobbying Disclosure Act filings through Jul 17, 2026. A filing shows who paid to lobby on a bill it names, not what changed.